Pfizer/BioNTech and Moderna vaccines induce T-cell immunity against SARS-CoV-2
Researchers in the United States have shown that the Pfizer/BioNTech and Moderna messenger RNA (mRNA) vaccines are effective at generating
Read more
SARS-CoV-2 virus neutralized with half-second exposure to very high temperature
Researchers in the United States have shown that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes
Read more
SARS-CoV-2 nucleoprotein can trigger α-synuclein amyloid fibril formation
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a primarily respiratory virus. It is the causative agent of the
Read more
FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19
Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody
Read more
Future attempts to reduce Covid-19 spread should focus on tackling airborne transmission
Any future attempts to reduce the spread of covid-19 should be focused on tackling close airborne transmission of the virus
Read more
No evidence B.1.1.7. variant worsens symptoms or increases risk of long COVID
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), spreads globally, new
Read more
Screening for SARS-CoV-2 non-structural protein 14 inhibitors
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome generates 16 distinct non-structural proteins (nsp) that constitute the enzymes and
Read more
Researchers unveil new SARS-CoV-2 inhibitor that targets viral immune evasion
In a recent quest for an effective antiviral compound, UK researchers have purified a specific enzyme of the severe acute
Read more
Children less infectious than adults with SARS-CoV-2
Children may not be as infectious in spreading SARS-CoV-2 to others as previously thought, according to new University of Manitoba-led
Read more
Researchers identify several novel SARS-CoV-2 inhibitors
Researchers in London, UK, have identified several compounds with SARS-CoV-2 inhibiting properties, that potentially may be developed into antiviral solutions
Read more